FOGHORN THERAPEUTICS INC's ticker is FHTX and the CUSIP is 344174107. A total of 64 filers reported holding FOGHORN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $63,370,600 | -29.0% | 12,674,120 | 0.0% | 4.60% | +15.5% |
| Q2 2023 | $89,225,805 | +13.5% | 12,674,120 | 0.0% | 3.98% | +30.4% |
| Q1 2023 | $78,579,544 | -2.8% | 12,674,120 | 0.0% | 3.05% | +18.3% |
| Q4 2022 | $80,860,886 | -25.6% | 12,674,120 | 0.0% | 2.58% | -43.6% |
| Q3 2022 | $108,744,000 | -36.9% | 12,674,120 | 0.0% | 4.58% | -29.5% |
| Q2 2022 | $172,368,000 | -10.7% | 12,674,120 | 0.0% | 6.49% | +43.3% |
| Q1 2022 | $193,027,000 | -33.4% | 12,674,120 | 0.0% | 4.53% | +1.1% |
| Q4 2021 | $289,857,000 | +64.2% | 12,674,120 | 0.0% | 4.48% | +142.3% |
| Q3 2021 | $176,551,000 | +30.6% | 12,674,120 | 0.0% | 1.85% | +7.1% |
| Q2 2021 | $135,233,000 | -19.0% | 12,674,120 | 0.0% | 1.73% | -35.4% |
| Q1 2021 | $167,045,000 | -35.0% | 12,674,120 | 0.0% | 2.68% | -42.8% |
| Q4 2020 | $256,905,000 | – | 12,674,120 | – | 4.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 1,261,261 | $17,153,000 | 14.59% |
| Flagship Pioneering Inc. | 12,674,120 | $172,368,000 | 6.49% |
| Birchview Capital, LP | 284,843 | $3,874,000 | 2.82% |
| Artal Group S.A. | 1,720,720 | $23,402,000 | 1.25% |
| Alphabet Inc. | 500,901 | $6,812,000 | 0.37% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 777,525 | $10,574,000 | 0.22% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 382,940 | $5,208,000 | 0.08% |
| XTX Topco Ltd | 11,436 | $156,000 | 0.06% |
| Virtus ETF Advisers LLC | 8,198 | $111,000 | 0.04% |
| Dynamic Technology Lab Private Ltd | 20,551 | $279,000 | 0.03% |